CD39 expression was more widespread, being present in a subset of cells of all types (39% in total), although the strongest and most frequent CD39 expressors were tumor-associated microglia, dendritic cells (DC) and other myeloid cells (in addition to some CD39hi lymphoid cells; (Fig. 2G, H). The gene discussed is ENTPD1; the disease is neoplasm.